References
- Alberti C (2006). Prostate cancer progression and surrounding microenvironment. Int J Biol Markers, 21, 88-95.
- Astin JW, Batson J, Kadir S, et al (2010). Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol, 12, 1194-204. https://doi.org/10.1038/ncb2122
- Berger MF, Lawrence MS, Demichelis F, et al (2011). The genomic complexity of primary human prostate cancer. Nature, 470, 214-20. https://doi.org/10.1038/nature09744
- Bonkhoff H (1998). Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status. Prostate Suppl, 8, 18-22.
- Boormans J, Korsten H, Ziel-van Der Made A, et al (2010). E17K substitution in AKT1 in prostate cancer. Bri J cancer, 102, 1491-4. https://doi.org/10.1038/sj.bjc.6605673
- Bubendorf L, Schopfer A, Wagner U, et al (2000). Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol, 31, 578-83. https://doi.org/10.1053/hp.2000.6698
- Chandran U, Ma C, Dhir R, et al (2007). Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer, 7, 64. https://doi.org/10.1186/1471-2407-7-64
- Chen T, Yi SH, Liu XY, Liu ZG (2012). Meta-analysis of Associations between the MDM2-T309G polymorphism and prostate cancer risk. Asian Pac J Cancer Prev, 13, 4327-30. https://doi.org/10.7314/APJCP.2012.13.9.4327
- Chung LW, Baseman A, Assikis V, Zhau HE (2005). Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol, 173, 10-20. https://doi.org/10.1097/01.ju.0000141582.15218.10
- Cornet AM, Hanon E, Reiter ER, et al (2003). Prostatic androgen repressed message-1 (PARM-1) may play a role in prostatic cell immortalisation. Prostate, 56, 220-30. https://doi.org/10.1002/pros.10254
- Dakhova O, Ozen M, Creighton CJ, et al (2009). Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res, 15, 3979-89. https://doi.org/10.1158/1078-0432.CCR-08-1899
- Fladeby C, Gupta SN, Barois N, et al (2008). Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells. Int J Cancer, 122, 1229-35.
- Fujita A, Gomes LR, Sato JR, et al (2008). Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates. BMC Syst Biol, 2, 106. https://doi.org/10.1186/1752-0509-2-106
- Glinsky GV, Glinskii AB, Stephenson AJ, et al (2004). Gene expression profiling predicts clinical outcome of prostate cancer. J Clini Invetst, 113, 913-23. https://doi.org/10.1172/JCI20032
- Gorlov I, Byun J, Gorlova O, et al (2009). Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data. BMC Med Genomics, 2, 48. https://doi.org/10.1186/1755-8794-2-48
- Guo YJ, Shi ZM, Liu JD, et al (2012). Meta-analysis of the relation between the VDR gene TaqIpolymorphism and genetic susceptibility to prostate cancer in Asian populations. Asian Pac J Cancer Prev, 13, 4441-4. https://doi.org/10.7314/APJCP.2012.13.9.4441
- Harris M, Clark J, Ireland A, et al (2004). The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res, 32, D258. https://doi.org/10.1093/nar/gkh036
- Hudson RS, Yi M, Esposito D, et al (2012). MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res, 40, 3689-703 . https://doi.org/10.1093/nar/gkr1222
- Jiang WG, Puntis MC, Hallett MB (1994). Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg, 81, 1576-90. https://doi.org/10.1002/bjs.1800811107
- Jing L, Liu L, Yu YP, et al (2004). Expression of myopodin induces suppression of tumor growth and metastasis. Am J Pathol, 164, 1799-806. https://doi.org/10.1016/S0002-9440(10)63738-8
- Kanehisa M (2002). The KEGG database. Novartis Found Symp, 247, 91-101; discussion -3, 19-28, 244-52.
- Korkola JE, Houldsworth J, Feldman DR, et al (2009). Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol, 27, 5240-7. https://doi.org/10.1200/JCO.2008.20.0386
- Liu R, Zhou Z, Huang J, Chen C (2011). PMEPA1 promotes androgen receptor-negative prostate cell proliferation through suppressing the Smad3/4-c-Myc-p21 Cip1 signaling pathway. J Pathol, 223, 683-94. https://doi.org/10.1002/path.2834
- Logothetis CJ, Lin SH (2005). Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer, 5, 21-8. https://doi.org/10.1038/nrc1528
- Love HD, Booton SE, Boone BE, et al (2009). Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer. PLoS One, 4, e8384. https://doi.org/10.1371/journal.pone.0008384
- Maere S, Heymans K, Kuiper M (2005). BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics, 21, 3448-9. https://doi.org/10.1093/bioinformatics/bti551
- Mathivanan S, Periaswamy B, Gandhi T, et al (2006). An evaluation of human protein-protein interaction data in the public domain. BMC Bioinformatics, 7, S19.
- McCabe CD, Spyropoulos DD, Martin D, Moreno CS (2008). Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer. Cancer Res, 68, 1988-96. https://doi.org/10.1158/0008-5472.CAN-07-5843
- Rhea JM, Singh HV, Molinaro RJ (2011). Next generation sequencing in the clinical molecular diagnosis of cancer. Medical Laboratory Observer.
- Rochester MA, Riedemann J, Hellawell GO, et al (2004). Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Ther, 12, 90-100.
- Savinainen KJ, Saramaki OR, Linja MJ, et al (2002). Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer. Am J Pathol, 160, 339. https://doi.org/10.1016/S0002-9440(10)64377-5
- Shannon P, Markiel A, Ozier O, et al (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13, 2498-504. https://doi.org/10.1101/gr.1239303
- Shen MM, Abate-Shen C (2010). Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev, 24, 1967-2000. https://doi.org/10.1101/gad.1965810
- Stangelberger A, Waldert M, Djavan B (2008). Prostate cancer in elderly men. Rev Urol, 10, 111.
- Tuxhorn JA, Ayala GE, Rowley DR (2001). Reactive stroma in prostate cancer progression. J Urol, 166, 2472-83. https://doi.org/10.1016/S0022-5347(05)65620-0
Cited by
- Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1/2-mediated matrix metalloproteinase-3 secretion vol.11, pp.4, 2014, https://doi.org/10.3892/mmr.2014.3097
- A Novel All-trans Retinoid Acid Derivative N-(3-trifluoromethyl-phenyl)-Retinamide Inhibits Lung Adenocarcinoma A549 Cell Migration through Down-regulating Expression of Myosin Light Chain Kinase vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7687
- Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer vol.11, pp.1, 2016, https://doi.org/10.1371/journal.pone.0147409
- Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3 vol.17, pp.5, 2016, https://doi.org/10.3390/ijms17050738